Trafficking and Endosomal Sorting of APP and BACE-1
APP 和 BACE-1 的运输和内体分选
基本信息
- 批准号:9268509
- 负责人:
- 金额:$ 31.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-11 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Abeta synthesisAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAxonBiogenesisBiological AssayBiological Response Modifier TherapyBrainBrain imagingCellsCleaved cellCollaborationsComplementCouplingDataDendritesDepositionDiseaseDistalEconomicsEndocytosisEndosomesEpidemicEventExocytosisFluorescenceFunctional disorderGenerationsGoalsGolgi ApparatusHumanImageIn SituLaboratoriesLeadLocationMembraneMicrofluidic MicrochipsModelingMolecularMusNeurogliaNeuronsOrganellesPathway interactionsPatientsPharmaceutical PreparationsPlayPresynaptic TerminalsProductionProteinsProteolysisRecyclingReportingResearchRoleRouteSiteSorting - Cell MovementSynapsesSynaptic VesiclesSystemTestingTherapeuticTimeToxic effectVesicleWorkabeta depositionamyloid precursor protein processingamyloidogenesisbeta secretasebeta-site APP cleaving enzyme 1experimental studygamma secretasein vivoinduced pluripotent stem cellinsightinterestnovelpresynapticpreventpublic health relevancesecretasesocialtooltraffickingtranscytosistwo-photon
项目摘要
DESCRIPTION (provided by applicant): The amyloid precursor protein (APP) is sequentially cleaved by ß- and γ-secretases to generate amyloid ß-peptide (Aß) in the brain - a central player in Alzheimer's disease. APP cleavage by ß-secretase-1 (BACE-1) is the rate-limiting step for production of Aß. Aß is believed to exert its toxicity on neurons while in a soluble and oligomeric state, prior to deposition as insoluble fibrils in brain. Thus, for reasons related to bth pathophysiology and therapeutics, understanding mechanisms and pathways of Aß generation from APP is a major focus of many laboratories. An intriguing aspect of Aß production is that its release is dependent upon neuronal activity - enhanced synaptic activity results in more Aß release. Though pathways involved in trafficking and cleavage of APP in neurons are of obvious importance, the vast majority of previous studies on APP/BACE-1 trafficking have been carried out in non-neuronal cells. These findings may not always be applicable to neurons, which are highly polarized and are known to have very different trafficking mechanisms. Furthermore, inferences on how neuronal activity modulates APP processing by BACE-1 require work in neurons. The prevailing view is that at presynaptic terminals, heightened synaptic vesicle recycling that accompanies high synaptic activity results in increased internalization into endosomes of APP where proteolysis by secretases take place. However, our recent studies using live neuronal imaging showed rather surprising results in that APP and BACE-1 normally traffic in distinct vesicles - perhaps preventing unabated cleavage - but converge in dendrites upon activity-induction. This led us to propose a new model whereby neuronal activity brings together APP and BACE-1 in dendrites where the two molecules interact. Only subsequently are these two molecules sorted into axons to distal terminals. Experiments in this proposal will examine a number of predictions that emanate from this working model and dissect the trafficking pathways of APP and BACE-1; revealing their relationship to amyloidogenesis and neuronal activity. Four Aims are proposed: 1) Test the hypothesis that APP and BACE-1 are first conveyed into dendrites in distinct carriers after biogenesis. 2) Determine specific neuronal
subcellular site(s) of APP/BACE-1 interaction and Aß release. 3) Determine the biogenesis and molecular composition of the axonal APP/BACE-1-carrying organelle. 4) Visualize APP/BACE-1 associations in brains and in human induced pluripotent stem cells (iPSCs). Collectively, results from these studies will provide new insights into the trafficking pathways of APP and BACE-1 and demonstrate how neuronal activity modulates these pathways to enhance APP cleavage and Aß release.
描述(由适用提供):淀粉样蛋白前体蛋白(APP)被β-和γ-分泌酶依次裂解,以在大脑中生成淀粉样蛋白β-肽(Aß) - 阿尔茨海默氏病的核心参与者。 β-分泌酶-1(BACE-1)的应用裂解是生产Aß的限制步骤。据信,Aß在可溶性和低聚物状态下将其毒性施加在神经元上,然后将其作为大脑中不溶性原纤维的沉积。出于与BTH的病理生理学和治疗有关的原因,了解APP的Aß产生的机制和途径是许多实验室的主要重点。 Aß产生的一个有趣的方面是,其释放取决于神经元活动 - 增强的突触活动会导致更多的Aß释放。尽管在神经元中涉及APP的贩运和分裂的途径显而易见,但在非神经元细胞中已经进行了以前的有关APP/BACE-1运输的绝大多数研究。这些发现可能并不总是适用于高度两极化且已知具有非常不同的运输机制的神经元。此外,关于神经元活动如何调节BACE-1的应用程序需要的推论需要在神经元中工作。当前的观点是,在突触前末端,涉及高突触活动的突触囊泡回收增强导致内在化增加了对APP的内体,在这种情况下,在这种情况下进行了分泌的蛋白水解。但是,我们最近使用活神经元成像的研究显示,该应用程序中的结果相当令人惊讶,而BACE -1通常会在不同的蔬菜中流动 - 可能会阻止裂解不减,但在活动诱导后会在树突中融合。这导致我们提出了一个新模型,在该模型中,神经元活性在两个分子相互作用的树突中将App和Bace-1汇总在一起。随后,这两个分子将轴突分类到不同的末端。该提案中的实验将检查许多从该工作模型中散发出来的预测,并剖析APP和BACE-1的贩运途径;揭示了它们与淀粉样生成和神经元活性的关系。提出了四个目的:1)检验以下假设:在生物发生后,在不同的载体中首先将APP和BACE-1传递到树突中。 2)确定特定的神经元
APP/BACE-1相互作用和Aß释放的亚细胞位点。 3)确定轴突应用程序/BACE-1携带细胞器的生物发生和分子组成。 4)可视化大脑和人类诱导多能干细胞(IPSC)中的APP/BACE-1关联。总的来说,这些研究的结果将为APP和BACE-1的运输途径提供新的见解,并证明神经元活动如何调节这些途径以增强APP裂解和Aß释放。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Subhojit Roy其他文献
Subhojit Roy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Subhojit Roy', 18)}}的其他基金
Testing Optimal Gene Editor for an Alzheimer's CRISPR therapeutic.
测试阿尔茨海默病 CRISPR 疗法的最佳基因编辑器。
- 批准号:
10746716 - 财政年份:2023
- 资助金额:
$ 31.37万 - 项目类别:
Pathophysiologic roles of alpha-synuclein at the synapse
α-突触核蛋白在突触中的病理生理作用
- 批准号:
10330337 - 财政年份:2021
- 资助金额:
$ 31.37万 - 项目类别:
Pathophysiologic roles of alpha-synuclein at the synapse
α-突触核蛋白在突触中的病理生理作用
- 批准号:
9765861 - 财政年份:2019
- 资助金额:
$ 31.37万 - 项目类别:
Pathophysiologic roles of alpha-synuclein at the synapse
α-突触核蛋白在突触中的病理生理作用
- 批准号:
10406165 - 财政年份:2019
- 资助金额:
$ 31.37万 - 项目类别:
Pathophysiologic roles of alpha-synuclein at the synapse
α-突触核蛋白在突触中的病理生理作用
- 批准号:
10164881 - 财政年份:2019
- 资助金额:
$ 31.37万 - 项目类别:
Pathophysiologic roles of alpha-synuclein at the synapse
α-突触核蛋白在突触中的病理生理作用
- 批准号:
10617745 - 财政年份:2019
- 资助金额:
$ 31.37万 - 项目类别:
A CRISPR-Cas9 screen to identify genetic modifiers of APP/BACE-1 interactions
用于鉴定 APP/BACE-1 相互作用的遗传修饰剂的 CRISPR-Cas9 筛选
- 批准号:
9074668 - 财政年份:2016
- 资助金额:
$ 31.37万 - 项目类别:
Trafficking and Endosomal Sorting of APP and BACE-1
APP 和 BACE-1 的运输和内体分选
- 批准号:
9330505 - 财政年份:2016
- 资助金额:
$ 31.37万 - 项目类别:
Trafficking and endosomal sorting of APP and BACE-1
APP 和 BACE-1 的运输和内体分选
- 批准号:
8912971 - 财政年份:2014
- 资助金额:
$ 31.37万 - 项目类别:
Trafficking and endosomal sorting of APP and BACE-1
APP 和 BACE-1 的运输和内体分选
- 批准号:
8753904 - 财政年份:2014
- 资助金额:
$ 31.37万 - 项目类别:
相似海外基金
Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
- 批准号:
10667987 - 财政年份:2023
- 资助金额:
$ 31.37万 - 项目类别:
miR-29: A brain homeostasis molecule for Alzheimer’s disease prevention
miR-29:一种用于预防阿尔茨海默病的大脑稳态分子
- 批准号:
10667151 - 财政年份:2023
- 资助金额:
$ 31.37万 - 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
- 批准号:
10629715 - 财政年份:2023
- 资助金额:
$ 31.37万 - 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
- 批准号:
10661931 - 财政年份:2023
- 资助金额:
$ 31.37万 - 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
- 批准号:
10722422 - 财政年份:2023
- 资助金额:
$ 31.37万 - 项目类别: